Related content

Off-Label Dermatologic Uses of Anti-TNF-a Therapies

By Alexis Andrew   Strober Bruce  

Journal of Cutaneous Medicine and Surgery, Vol. 9, Iss. 6, 2005-12 ,pp. : 296-302

Springer Publishing Company

Access to resources Recommend Favorite

Open label trial of alefacept in palmoplantar pustular psoriasis

By Carr David   Tusa Mark   Carroll Christie   Pearce Daniel   Camacho Fabian   Kaur Mandeep   Cook Christina   Willard Joy   McCarty Ann   Fleischer Alan   Liu Clive   Goffe Bernard   Feldman Steven  

Journal of Dermatological Treatment, Vol. 19, Iss. 2, 2008-01 ,pp. : 97-100

Informa Healthcare

Access to resources Recommend Favorite

The off-label use of biologic therapies in dermatology

By Lee Natasha   Savage Laura Jane  

Dermatological Nursing, Vol. 14, Iss. 1, 2015-03 ,pp. : 52-56

British Dermatological Nursing Group

Access to resources Recommend Favorite

Facial Superficial Granulomatous Pyoderma Treated with Cyclosporine: Not Always a Benign Condition

By Cheung Seau Tak   Zanetto Ulises   Diaz Camilo  

Acta Dermato-Venereologica, Vol. 86, Iss. 4, 2006-07 ,pp. : 362-363

Medical Journals Limited

Access to resources Recommend Favorite

Ustekinumab in nail psoriasis: an open-label, uncontrolled, nonrandomized study

By Patsatsi Aikaterini   Kyriakou Aikaterini   Sotiriadis Dimitrios  

Journal of Dermatological Treatment, Vol. 24, Iss. 2, 2013-04 ,pp. : 96-100

Informa Healthcare

Access to resources Recommend Favorite